Clinical Trial Results:
            Un Ensayo de Fase IIb, Aleatorizado,  Doble Ciego, Controlado con Placebo y Comparador Activo, de Determinación del Rango de Dosis  para Evaluar los Efectos de MK-5442 en la Densidad Mineral Ósea (DMO) en el Tratamiento de la Osteoporosis en Mujeres Posmenopáusicas Tratadas Anteriormente con un Bifosfonato Oral
"A Phase IIb, Randomized, Double-Blind, Placebo- and Active-Controlled, Dose-Range-Finding Study to Evaluate the Effects of MK-5442 on Bone Mineral Density (BMD) in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated with an Oral Bisphosphonate"
    
|     Summary | |
|     EudraCT number | 2009-014729-18 | 
|     Trial protocol | ES GB CZ DK PL FR | 
|     Global completion date | 
                                    16 Jun 2011
                             | 
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | 
                                        No
                                 | 
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    29 Jun 2016
                             | 
|     First version publication date | 
                                    29 Jun 2016
                             | 
|     Other versions | |
|     Summary report(s) | clinicaltrials.gov record including results | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
